This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Schädlich PK, Kentsch M, Weber M, Kämmerer W, Brecht JG, Nadipelli V, Huppertz E.Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany. PharmacoEconomics 24: 571-591, No. 6, 2006
Rights and permissions
About this article
Cite this article
Enoxaparin sodium cost effective for VTE prophylaxis. Pharmacoecon. Outcomes News 507, 7 (2006). https://doi.org/10.2165/00151234-200605070-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605070-00011